Elicio Therapeutics, Inc. Common Stock, Shares, Outstanding from Q4 2020 to Q3 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Elicio Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2020 to Q3 2025.
  • Elicio Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending September 30, 2025 was 17.3M shares, a 60% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)

Elicio Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 17.3M +6.47M +60% Sep 30, 2025 10-Q 2025-11-13
Q2 2025 16.3M +6M +58.5% Jun 30, 2025 10-Q 2025-08-07
Q1 2025 16M +5.75M +56.3% Mar 31, 2025 10-Q 2025-05-13
Q4 2024 11M +1.43M +14.8% Dec 31, 2024 10-Q 2025-11-13
Q3 2024 10.8M +2.41M +28.7% Sep 30, 2024 10-Q 2024-11-13
Q2 2024 10.3M +1.89M +22.6% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 10.2M -19.9M -66.1% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 9.6M +9.28M +2899% Dec 31, 2023 10-K 2025-03-31
Q3 2023 8.38M -21.7M -72.2% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 8.37M -21.7M -72.1% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 30.1M +155K +0.52% Mar 31, 2023 10-Q 2023-05-10
Q4 2022 320K -29.6M -98.9% Dec 31, 2022 10-K 2024-03-29
Q3 2022 30.1M +180K +0.6% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 30.1M +255K +0.86% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 30M +299K +1.01% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 30M +14.6M +95.6% Dec 31, 2021 10-K 2023-03-17
Q3 2021 29.9M Sep 30, 2021 10-Q 2021-11-12
Q2 2021 29.8M Jun 30, 2021 10-Q 2021-08-12
Q1 2021 29.7M Mar 31, 2021 10-Q 2021-05-17
Q4 2020 15.3M Dec 31, 2020 10-K 2022-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.